合計 50 件の最近のインサイダー取引記録が記録されています Tarsus Pharmaceuticals, Inc. (TARS), 内訳は 9 件の買い および 38 件の売り. インサイダー買い総額は RSU アワード インサイダー売り総額は $8.71M.
最近活動のある主要インサイダーには Neervannan Seshadri, Farrow Jeffrey S, Mottiwala Aziz. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — TARS
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-20 |
Neervannan Seshadri |
Chief Operating Officer |
情報に基づく売り |
2,989 |
$66.75 |
$199.52K |
82,791 |
| 2026-03-19 |
Farrow Jeffrey S |
See Remarks |
情報に基づく売り |
2,186 |
$67.00 |
$146.46K |
43,316 |
| 2026-03-19 |
Mottiwala Aziz |
Chief Commercial Officer |
情報に基づく売り |
4,440 |
$67.00 |
$297.48K |
61,480 |
| 2026-03-19 |
Neervannan Seshadri |
Chief Operating Officer |
情報に基づく売り |
4,589 |
$67.00 |
$307.46K |
85,780 |
| 2026-03-19 |
Azamian Bobak R. |
President/ceo and Board Chair |
情報に基づく売り |
11,964 |
$67.00 |
$801.59K |
33,421 |
| 2026-03-19 |
Whitfield Dianne C. |
Chief Human Resources Officer |
情報に基づく売り |
4,174 |
$67.00 |
$279.66K |
35,028 |
| 2026-03-19 |
Wahl Bryan |
General Counsel |
情報に基づく売り |
4,231 |
$67.00 |
$283.48K |
63,959 |
| 2026-03-19 |
Lin Elizabeth Yeu |
Chief Medical Officer |
情報に基づく売り |
390 |
$67.00 |
$26.13K |
23,308 |
| 2026-03-18 |
Farrow Jeffrey S |
See Remarks |
情報に基づく売り |
2,133 |
$68.71 |
$146.56K |
45,502 |
| 2026-03-18 |
Mottiwala Aziz |
Chief Commercial Officer |
情報に基づく売り |
4,330 |
$68.71 |
$297.51K |
65,920 |
| 2026-03-18 |
Neervannan Seshadri |
Chief Operating Officer |
情報に基づく売り |
3,610 |
$68.71 |
$248.04K |
90,369 |
| 2026-03-18 |
Azamian Bobak R. |
President/ceo and Board Chair |
情報に基づく売り |
11,667 |
$68.71 |
$801.64K |
45,385 |
| 2026-03-18 |
Whitfield Dianne C. |
Chief Human Resources Officer |
情報に基づく売り |
4,071 |
$68.71 |
$279.72K |
39,202 |
| 2026-03-18 |
Wahl Bryan |
General Counsel |
情報に基づく売り |
4,125 |
$68.71 |
$283.43K |
68,190 |
| 2026-03-18 |
Lin Elizabeth Yeu |
Chief Medical Officer |
情報に基づく売り |
379 |
$68.71 |
$26.04K |
23,698 |
| 2026-03-17 |
Farrow Jeffrey S |
See Remarks |
情報に基づく売り |
2,111 |
$69.42 |
$146.55K |
47,635 |
| 2026-03-17 |
Mottiwala Aziz |
Chief Commercial Officer |
情報に基づく売り |
4,286 |
$69.42 |
$297.53K |
70,250 |
| 2026-03-17 |
Neervannan Seshadri |
Chief Operating Officer |
情報に基づく売り |
3,125 |
$69.42 |
$216.94K |
93,979 |
| 2026-03-17 |
Azamian Bobak R. |
President/ceo and Board Chair |
情報に基づく売り |
10,972 |
$69.42 |
$761.68K |
57,052 |
| 2026-03-17 |
Whitfield Dianne C. |
Chief Human Resources Officer |
情報に基づく売り |
4,029 |
$69.42 |
$279.69K |
43,273 |
| 2026-03-17 |
Wahl Bryan |
General Counsel |
情報に基づく売り |
4,084 |
$69.42 |
$283.51K |
72,315 |
| 2026-03-17 |
Lin Elizabeth Yeu |
Chief Medical Officer |
情報に基づく売り |
375 |
$69.42 |
$26.03K |
24,077 |
| 2026-03-16 |
Link William J Phd |
Director |
情報に基づく売り |
493 |
$69.75 |
$34.39K |
116,332 |
| 2026-03-15 |
Farrow Jeffrey S |
See Remarks |
オプション行使（売却） |
5,022 |
- |
- |
15,067 |
| 2026-03-15 |
Mottiwala Aziz |
Chief Commercial Officer |
オプション行使（売却） |
4,790 |
- |
- |
- |
| 2026-03-15 |
Neervannan Seshadri |
Chief Operating Officer |
オプション行使（売却） |
5,097 |
- |
- |
- |
| 2026-03-15 |
Azamian Bobak R. |
President/ceo and Board Chair |
オプション行使（売却） |
11,300 |
- |
- |
- |
| 2026-03-15 |
Whitfield Dianne C. |
Chief Human Resources Officer |
オプション行使（売却） |
4,463 |
- |
- |
- |
| 2026-03-15 |
Wahl Bryan |
General Counsel |
オプション行使（売却） |
4,790 |
- |
- |
- |
| 2026-03-15 |
Lin Elizabeth Yeu |
Chief Medical Officer |
オプション行使（売却） |
2,511 |
- |
- |
7,534 |
| 2026-03-05 |
Farrow Jeffrey S |
See Remarks |
RSU 付与（制限付株式） |
19,306 |
- |
- |
19,306 |
| 2026-03-05 |
Mottiwala Aziz |
Chief Commercial Officer |
RSU 付与（制限付株式） |
19,306 |
- |
- |
19,306 |
| 2026-03-05 |
Neervannan Seshadri |
Chief Operating Officer |
RSU 付与（制限付株式） |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Azamian Bobak R. |
President/ceo and Board Chair |
RSU 付与（制限付株式） |
60,776 |
- |
- |
60,776 |
| 2026-03-05 |
Whitfield Dianne C. |
Chief Human Resources Officer |
RSU 付与（制限付株式） |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Wahl Bryan |
General Counsel |
RSU 付与（制限付株式） |
17,161 |
- |
- |
17,161 |
| 2026-03-05 |
Lin Elizabeth Yeu |
Chief Medical Officer |
RSU 付与（制限付株式） |
17,161 |
- |
- |
17,161 |
| 2026-03-04 |
Neervannan Seshadri |
Chief Operating Officer |
情報に基づく売り |
8,366 |
$76.67 |
$641.42K |
70,817 |
| 2026-02-18 |
Pyott David E I |
Director |
不明 |
7,000 |
$12.97 |
$90.79K |
- |
| 2026-02-18 |
Pyott David E I |
Director |
RSU 付与（制限付株式） |
3,729 |
- |
- |
3,729 |
| 2026-01-02 |
Whitfield Dianne C. |
Chief Human Resources Officer |
情報に基づく売り |
893 |
$82.93 |
$74.06K |
23,393 |
| 2025-12-24 |
Azamian Bobak R. |
President/ceo and Board Chair |
情報に基づく売り |
557 |
$83.54 |
$46.53K |
857,991 |
| 2025-12-16 |
Lin Elizabeth Yeu |
Chief Medical Officer |
情報に基づく売り |
2,078 |
$79.50 |
$165.2K |
21,941 |
| 2025-12-16 |
Neervannan Seshadri |
Chief Operating Officer |
贈与（受領） |
475 |
- |
- |
475 |
| 2025-12-16 |
Whitfield Dianne C. |
Chief Human Resources Officer |
情報に基づく売り |
7,397 |
$80.10 |
$592.5K |
38,958 |
| 2025-12-15 |
Goodrich Katherine |
Director |
オプション行使 |
2,233 |
- |
- |
2,233 |
| 2025-12-15 |
Link William J Phd |
Director |
情報に基づく売り |
4,766 |
$81.50 |
$388.43K |
- |
| 2025-12-15 |
Lin Elizabeth Yeu |
Chief Medical Officer |
オプション行使（売却） |
6,819 |
- |
- |
20,459 |
| 2025-12-04 |
Azamian Bobak R. |
President/ceo and Board Chair |
贈与（送付） |
51,885 |
- |
- |
1,750 |
| 2025-09-24 |
Azamian Bobak R. |
President/ceo and Board Chair |
情報に基づく売り |
6,000 |
$55.37 |
$332.22K |
812,106 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
